WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Pulsed Abraxane and Radiotherapy for Improving and Maintaining Ambulation After Cancer-Related Cord Compression

Phase 2

Terminated

Conditions: Cord Compression

Interventions: Radiation: Radiation therapy
Drug: nab-Paclitaxel

First Posted Date: 2018-08-31

Last Posted Date: 2025-02-04

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 2

Registration Number: NCT03655080

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Abemaciclib + Nivolumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed or Recurred Within Six Months After Platinum-based Chemotherapy

Phase 1

Terminated

Conditions: Head and Neck Squamous Cell Carcinoma

Interventions: Drug: Abemaciclib
Drug: Nivolumab
Procedure: Tumor biopsy
Procedure: Peripheral blood
Other: EORTC QLQ-30

First Posted Date: 2018-08-31

Last Posted Date: 2020-12-03

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 6

Registration Number: NCT03655444

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Brain Stimulation and Enhancing Cognition in Older Adults

Not Applicable

Completed

Conditions: Depressive Symptoms
Anxiety
Cognitive Impairment, Mild

Interventions: Device: Active Transcranial Direct Current Stimulation (tDCS)
Device: Sham Transcranial Direct Current Stimulation (tDCS)

First Posted Date: 2018-08-31

Last Posted Date: 2021-07-08

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 26

Registration Number: NCT03653351

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
🇺🇸
Washington University in Saint Louis, Saint Louis, Missouri, United States

Ramucirumab + Pembrolizumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Phase 1

Active, not recruiting

Conditions: Head and Neck Squamous Cell Carcinoma

Interventions: Drug: Ramucirumab
Drug: Pembrolizumab
Procedure: Peripheral blood
Other: EORTC QLQ-30
Other: FACT H&N

First Posted Date: 2018-08-29

Last Posted Date: 2024-12-27

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 43

Registration Number: NCT03650764

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Treatment of High-Risk Moderate Acute Malnutrition Using Expanded Admission Criteria

Not Applicable

Completed

Conditions: Malnutrition

Interventions: Behavioral: Mother Care group
Drug: amoxicillin
Dietary Supplement: Ready-to-use therapeutic food (RUTF)

First Posted Date: 2018-08-27

Last Posted Date: 2020-09-01

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 1322

Registration Number: NCT03647150

Locations: 🇸🇱
Project Peanut Butter, Freetown, Sierra Leone

Response Assessment in SB CD

Recruiting

Conditions: Small Bowel Crohn's Disease

First Posted Date: 2018-08-24

Last Posted Date: 2025-03-13

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 200

Registration Number: NCT03646708

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Efficacy and Safety of a Quadruple Ultra-low-dose Treatment for Hypertension

Phase 2

Completed

Conditions: Hypertension

Interventions: Drug: QUARTET LDQT
Drug: Candesartan

First Posted Date: 2018-08-21

Last Posted Date: 2025-01-03

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 62

Registration Number: NCT03640312

Locations: 🇺🇸
ACCESS Martin T. Russo Family Health Center, Bloomingdale, Illinois, United States
🇺🇸
Ashland Family Health Center, Chicago, Illinois, United States

NSAIDs Stent Study

Early Phase 1

Recruiting

Conditions: Ureteral Stent Placement
Kidney Stone

Interventions: Drug: Normal saline
Drug: Ketorolac Trometamol 30Mg/1mL Injection

First Posted Date: 2018-08-20

Last Posted Date: 2024-10-30

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 36

Registration Number: NCT03638999

Locations: 🇺🇸
Washington University, Saint Louis, Missouri, United States

Improving Characterization of Calcifications With Contrast-Enhanced Mammography

Not Applicable

Withdrawn

Conditions: Mammography

Interventions: Device: Contrast-enhanced mammography
Procedure: Biopsy

First Posted Date: 2018-08-20

Last Posted Date: 2019-05-14

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT03639129

Hyponatremia Study (Delayed Hyponatremia After Pituitary Surgery)

Not Applicable

Completed

Conditions: Hyponatremic
Pituitary
Hyponatremia
Pituitary Tumor
Surgery

Interventions: Other: Fluid Restricted Group

First Posted Date: 2018-08-17

Last Posted Date: 2024-07-23

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 300

Registration Number: NCT03636568

Locations: 🇺🇸
Barnes Jewish Hospital, Saint Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy